Clinical trial
SMOOTH - Blood Pressure Control in Diabetic/Obese Patients
NCT00239538 · Boehringer Ingelheim, Industry · Completed
Key facts
| NCT number | NCT00239538 |
|---|---|
| Title | SMOOTH - Blood Pressure Control in Diabetic/Obese Patients |
| Official title | Prospective, Randomized, Open-label, Blinded Endpoint, Forced Titration Study to Compare Telmisartan Combined With HCTZ (80mg/12.5mg), to Valsartan Combined With HCTZ (160mg/12.5mg), for the Control of Mild-to-moderate Hypertension in Obese Patients With Type 2 Diabetes Mellitus Using ABPM. |
| Lead sponsor | Boehringer Ingelheim, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Hypertension, Diabetes Mellitus, Type 2 |
| Intervention type | Drug |
| Interventions | telmisartan combined with hydrochlorothiazide (80/12.5 mg), valsartan combined with hydrochlorothiazide (160/12.5mg) |
| Enrollment | 840 |
| Start date | Jan 1, 2003 |
| Primary completion | Dec 1, 2004 |
| Completion | Dec 1, 2004 |
| First posted | Oct 17, 2005 |
| Last update posted | Nov 8, 2013 |
| Countries | Argentina, Australia, Canada, Mexico, New Zealand, South Korea, Taiwan, United States |
At a glance
- 100–999 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: